Target intelligence / Profile preview

Acinetobacter baumannii cell envelope

Molecular classification
Bacterial cell envelope, Gram-negative outer membrane, Lipopolysaccharide transport system, Peptidoglycan layer
01

Overview

The Acinetobacter baumannii cell envelope is a complex, multi-layered structure that serves as the primary interface between the bacterium and its environment. It consists of an inner cytoplasmic membrane, a periplasmic space containing a thin peptidoglycan layer, and a highly asymmetric outer membrane composed of phospholipids and lipopolysaccharides (LPS) [4, 5]. This envelope acts as a formidable permeability barrier, which is a major factor in the pathogen's multi-drug resistance (MDR) and its ability to survive in harsh clinical environments [5]. Therapeutic strategies targeting this structure include the use of polymyxins, which disrupt membrane stability by binding to LPS, and novel inhibitors like zosurabalpin, which block the essential transport of LPS to the cell surface [1, 2]. Because the envelope is vital for structural integrity and protection against host immune defenses, it remains a critical target for the development of new antibiotics against carbapenem-resistant strains [2, 5]. Citations: [1] Clinical Microbiology Reviews (2017) doi:10.1128/CMR.00064-16; [2] Nature (2024) doi:10.1038/s41586-023-06873-0; [3] Drugs (2019) doi:10.1007/s40265-019-01188-7; [4] Frontiers in Microbiology (2019) doi:10.3389/fmicb.2019.02183; [5] International Journal of Molecular Sciences (2021) doi:10.3390/ijms22168828.

Other names
Acinetobacter baumannii outer membraneA. baumannii cell wallAcinetobacter baumannii envelopeGram-negative cell envelope
02

Mechanism of action

Drugs targeting the Acinetobacter baumannii cell envelope act through several distinct mechanisms: polymyxins (Colistin, Polymyxin B) bind to the lipid A component of lipopolysaccharides (LPS), displacing divalent cations and disrupting the physical integrity of the outer membrane [1]; zosurabalpin inhibits the LptB2FGC complex, which is responsible for transporting LPS from the inner membrane to the outer membrane, leading to LPS accumulation in the periplasm and bacterial death [2]; and beta-lactams like carbapenems inhibit penicillin-binding proteins (PBPs) involved in peptidoglycan synthesis within the cell envelope [5].

03

Biological functions

Selective permeability barrierStructural integrityProtection against host immune responseNutrient acquisition and transportEfflux of toxic substancesAdhesion and biofilm formation
04

Disease associations

InfectionHospital-acquired pneumoniaSepticemiaUrinary tract infectionMeningitisWound infection
05

Safety considerations

Nephrotoxicity (particularly with polymyxins) [1]Neurotoxicity [1]Rapid emergence of resistance through LPS modification or loss [4]Potential for Jarisch-Herxheimer-like reactions due to rapid LPS release
06

Interacting drugs

Colistin (Polymyxin E)

5 more in the full profile.

07

Biomarkers

Carbapenem-resistant Acinetobacter baumannii (CRAB) phenotypemcr-1 to mcr-10 gene expression (polymyxin resistance)LPS modification markers (e.g., pmrCAB mutations)Porin expression levels (e.g., CarO, OmpA)

Beyond the preview

Go deeper on Acinetobacter baumannii cell envelope.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acinetobacter baumannii cell envelope.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call